Latest Share Chat

REMOVE ADS

Astrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

14,318.00 256.00 (1.82%)

Bid:

14,256.00

Ask:

14,262.00

Spread: 6.00 (0.042%)

Market Cap: £222.05b

Last checked at -

Intraday Astrazeneca Share Chart

REMOVE ADS

Astrazeneca News

AstraZeneca says Tezspire and Koselugo recommended for approval in EU

(Alliance News) - AstraZeneca PLC on Monday said two drugs have been recommended for approval by the Committee for Medicinal Products for Human Use of...

LONDON BRIEFING: Wilmington profit declines; Elixirr earnings improve

(Alliance News) - London's FTSE is set to open lower on Monday, following a rate hold by China's central bank and the risk of heightened geopolitical ...

EU approves AstraZeneca's Tezspire to treat nasal conditions

(Sharecast News) - AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment ...

AstraZeneca says Ultomiris shows 3 years relapse-free in NMOSD

(Alliance News) - AstraZeneca PLC on Friday said new long-term clinical trial data reinforce Ultomiris as a transformative treatment for neuromyelitis...

LONDON BROKER RATINGS: Deutsche Bank Research cuts Eurowag to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

AstraZeneca lupus drug succeeds in trial as COPD therapy fails

(Alliance News) - AstraZeneca PLC on Wednesday reported mixed updates from its late-stage pipeline, with a lupus treatment hitting its main goal in a ...

GSK commits $30 billion to US research and development, factory expansion, as Trump visits UK

GSK plans $30 billion investment in U.S. over next five years *

UK and US strike tech deal as Trump arrives for state visit

(Alliance News) - Britain and the US have struck a tech deal that could bring billions of pounds of investment to the UK as President Donald Trump arr...